Malcolm Hedgcock
ORCID：0000-0001-7510-2173
发表论文 17 篇 · 总被引 262 次 · h-index 7
代表论文
- Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy (2022 · npj Vaccines · 被引 100)
- People With Human Immunodeficiency Virus Receiving Suppressive Antiretroviral Therapy Show Typical Antibody Durability After Dual Coronavirus Disease 2019 Vaccination and Strong Third Dose Responses (2022 · The Journal of Infectious Diseases · 被引 49)
- Antibody response durability following three-dose coronavirus disease 2019 vaccination in people with HIV receiving suppressive antiretroviral therapy (2022 · AIDS · 被引 24)
- Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy (2021 · medRxiv · 被引 23)
- People with HIV receiving suppressive antiretroviral therapy show typical antibody durability after dual COVID-19 vaccination, and strong third dose responses (2022 · medRxiv · 被引 20)
- Efficacy and Safety of Switching to Daily Bictegravir Plus Lenacapavir From a Complex HIV Treatment Regimen: A Randomized, Open-Label, Multicenter Phase 2 Study (ARTISTRY-1) (2024 · Clinical Infectious Diseases · 被引 10)